Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal

Clinical trial NCT01863186 · COMPLETED

Trial details

NCT number: NCT01863186
Sponsor: USWM, LLC (dba US WorldMeds)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid Dependence Acute Opioid Withdrawal Syndrome

Start date: 2013-06-01
Primary completion: 2014-11-01
Enrollment: 603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.